DEST — Destiny Pharma Share News
0.000.00%
Last trade - 00:00Result of Open Offer
Holding(s) in Company
Posting of Circular and Notice of General Meeting
Director/PDMR Shareholding
Brief: Destiny Pharma Announces Deal With Sebela Pharmaceutical For NTCD-M3
Brief: Destiny Pharma To Raise Up To 8 Million Stg
Issue of Equity
Agreement with Sebela Pharmaceutical for NTCD-M3
Price Monitoring Extension
Exercise of Options and Total Voting Rights
US Center for Disease Control review paper
UK's Destiny Pharma gains on nearing marketing deal for lead asset
Second Price Monitoring Extn
Price Monitoring Extension
Brief: Destiny Pharma To Finalise Phase 3 Plans For Xf-73 Nasal
Year End Trading Update
Brief: Destiny Pharma Finalizes Phase 3 Development Plans For XF-73 NASAL
FDA/CDC highlight need for infection preventions
XF-73 Nasal final Phase 3 development plans